Mehri Naghdalipour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mehri Naghdalipour has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abdoulreza Esteghamati
Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Afsane Gholamrezayi
Department of Nutrition, School of Public Health–International Campus Iran University of Medical Sciences Tehran Iran
1 shared publication- Ahmad Tavakoli
Biological Products and Blood Safety Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
1 shared publication - Ahmadi-Vasmehjani
Department of Virology School of Public Health Tehran University of Medical Sciences Tehran 1416753955 Iran
1 shared publication - Elham Chamani
Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran - Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication - Farzaneh Rahvar
Department of Medical Genetics, Institute of Medical Biotechnology National Institute of Genetic Engineering and Biotechnology (NIGEB) Tehran Iran
1 shared publication
Latest Publications
- 13 January 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (1) , 27-41
A meta-analysis On Association Between Viral Infections and Kawasaki Disease in Children
Aim: To investigate the association between different viral infections and the development of Kawasaki disease (KD) in children. Materials & methods: Electronic databases were searched for relevant...
- 13 January 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (1) , 27-41
A meta-analysis On Association Between Viral Infections and Kawasaki Disease in Children
Aim: To investigate the association between different viral infections and the development of Kawasaki disease (KD) in children. Materials & methods: Electronic databases were searched for relevant...
- Open Access
- 20 April 2020
- Published by Wiley in IUBMB Life
- Vol. 72 (8) , 1698-1704
Serum levels of C1q/TNF‐related protein‐3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance
Ulcerative colitis (UC) and Crohn's disease (CD) are two major forms of inflammatory bowel disease (IBD), which is an inflammatory disease. Studies have shown that adipose tissue and inflammation play important roles in the pathogenesis of IBD. C1q/TNF‐related protein‐3 (CTRP3) is a newly discovered adipokine playing a substantial role during inflammatory process, and for the first time in the present study, serum levels of this adipokine were measured in the UC and CD patients. This case–control study included 70 control, 50 UC, and 50 CD patients who were diagnosed by standard criteria. Serum levels of adiponectin, IL‐6, TNF‐α, TGF‐β, and CTRP3 were evaluated using ELISA kits. Serum levels of IL‐6, TNF‐α, and TGF‐β elevated in the UC and CD patients compared with the controls while adiponectin and CTRP3 diminished in the patient's groups compared with the control. Furthermore, decrease in CTRP3 serum levels was associated with the risk of UC and CD diseases. Moreover, CTRP3 indicated negative correlation with BMI, FBS, insulin, homeostasis model assessment of insulin resistance, IL‐6, TNF‐α, and TGF‐β and also a positive correlation with adiponectin in both the UC and CD patients. For the first time, the present study demonstrated lower levels of CTRP3 in the UC and CD patients. Decreased serum levels of CTRP3 and its inverse relationship with inflammatory cytokines and TGF‐β levels suggested a possible role for CTRP3 in the pathogenesis of UC and CD diseases.
- 20 April 2020
- Published by Wiley in IUBMB Life
- Vol. 72 (8) , 1698-1704
Open AccessSerum levels of C1q/TNF‐related protein‐3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance
Ulcerative colitis (UC) and Crohn's disease (CD) are two major forms of inflammatory bowel disease (IBD), which is an inflammatory disease. Studies have shown that adipose tissue and inflammation play important roles in the pathogenesis of IBD. C1q/TNF‐related protein‐3 (CTRP3) is a newly discovered adipokine playing a substantial role during inflammatory process, and for the first time in the present study, serum levels of this adipokine were measured in the UC and CD patients. This case–control study included 70 control, 50 UC, and 50 CD patients who were diagnosed by standard criteria. Serum levels of adiponectin, IL‐6, TNF‐α, TGF‐β, and CTRP3 were evaluated using ELISA kits. Serum levels of IL‐6, TNF‐α, and TGF‐β elevated in the UC and CD patients compared with the controls while adiponectin and CTRP3 diminished in the patient's groups compared with the control. Furthermore, decrease in CTRP3 serum levels was associated with the risk of UC and CD diseases. Moreover, CTRP3 indicated negative correlation with BMI, FBS, insulin, homeostasis model assessment of insulin resistance, IL‐6, TNF‐α, and TGF‐β and also a positive correlation with adiponectin in both the UC and CD patients. For the first time, the present study demonstrated lower levels of CTRP3 in the UC and CD patients. Decreased serum levels of CTRP3 and its inverse relationship with inflammatory cytokines and TGF‐β levels suggested a possible role for CTRP3 in the pathogenesis of UC and CD diseases.